Inhibitory KIRs decrease HLA class II-mediated protection in Type 1 Diabetes

• Laura Mora-Bitria,

  Roles Formal analysis, Investigation, Methodology, Software, Validation, Visualization, Writing – original draft, Writing – review & editing

  Affiliations Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom, Systems Pharmacology and Medicine, Bayer AG, Leverkusen, Germany

  https://orcid.org/0000-0002-0850-1833

  ⨯
• Bisrat J. Debebe,

  Roles Formal analysis, Methodology, Software

  Affiliation Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom

  ⨯
• Kelly L. Miners,

  Roles Investigation

  Affiliation Division of Infection and Immunity, Cardiff University School of Medicine, University Hospital of Wales, Cardiff, United Kingdom

  ⨯
• Kristin Ladell,

  Roles Investigation

  Affiliation Division of Infection and Immunity, Cardiff University School of Medicine, University Hospital of Wales, Cardiff, United Kingdom

  ⨯
• Charandeep Kaur,

  Roles Investigation

  Affiliation Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom

  ⨯
• James A. Traherne,

  Roles Resources

  Affiliation Immunology Division, Department of Pathology, University of Cambridge, Cambridge, United Kingdom

  ⨯
• Wei Jiang,

  Roles Resources

  Affiliation Immunology Division, Department of Pathology, University of Cambridge, Cambridge, United Kingdom

  ⨯
• David A. Price,

  Roles Resources

  Affiliations Division of Infection and Immunity, Cardiff University School of Medicine, University Hospital of Wales, Cardiff, United Kingdom, Systems Immunity Research Institute, Cardiff University School of Medicine, University Hospital of Wales, Cardiff, United Kingdom

  https://orcid.org/0000-0001-9416-2737

  ⨯
• Linda Hadcocks,

  Roles Investigation

  Affiliation Institute for Infection and Immunity, St George’s, University of London, London, United Kingdom

  https://orcid.org/0000-0003-1811-7146

  ⨯
• Nicholas A. R. McQuibban,

  Roles Formal analysis

  Affiliations Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom, Centre for Integrative Systems Biology and Bioinformatics (CISBIO), Department of Life Sciences, Imperial College London, London, United Kingdom

  ⨯
• John Trowsdale,

  Roles Resources

  Affiliation Immunology Division, Department of Pathology, University of Cambridge, Cambridge, United Kingdom

  ⨯
• F Susan Wong,

  Roles Resources

  Affiliation Division of Infection and Immunity, Cardiff University School of Medicine, University Hospital of Wales, Cardiff, United Kingdom

  ⨯
• Nikolas Pontikos,

  Roles Resources

  Affiliation UCL Institute of Ophthalmology, University College London, London, United Kingdom

  https://orcid.org/0000-0003-1782-4711

  ⨯
• Christoph Niederalt,

  Roles Funding acquisition, Project administration, Supervision

  Affiliation Systems Pharmacology and Medicine, Bayer AG, Leverkusen, Germany

  ⨯
• Becca Asquith

  Roles Conceptualization, Formal analysis, Funding acquisition, Project administration, Resources, Supervision, Validation, Visualization, Writing – original draft, Writing – review & editing

  * E-mail: b.asquith@imperial.ac.uk

  Affiliation Department of Infectious Disease, Faculty of Medicine, Imperial College London, London, United Kingdom

  https://orcid.org/0000-0002-5911-3160

  ⨯